Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease.

Melchior B, Garcia AE, Hsiung BK, Lo KM, Doose JM, Thrash JC, Stalder AK, Staufenbiel M, Neumann H, Carson MJ. Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease. ASN Neuro. 2010 Jul 12; 2(3):e00037.

View in: PubMed

subject areas

Alzheimer Disease
Amyloid
Animals
Cell Line, Transformed
Cells, Cultured
Gene Expression Regulation
Humans
Immunotherapy, Active
Membrane Glycoproteins
Mice
Mice, Inbred C57BL
Mice, Transgenic
Phagocytosis
Receptors, Immunologic

authors with profiles

Monica Carson

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support